NCT06760767

Brief Summary

Studies on pelvic floor physiotherapy in individuals diagnosed with vaginismus are quite limited in the literature. While current studies have focused on certain physiotherapy modalities, the literature is quite limited in terms of combined rehabilitation programs. There is a need for non-invasive therapy methods that can be an alternative for the patient and client population whose vaginismus problem continues after behavioral therapies. No studies on pelvic floor physiotherapy combined with sexual therapy have been found in the literature. In this context, our study aimed to examine the effectiveness of pelvic floor physiotherapy combined with sexual therapy in individuals diagnosed with vaginismus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

December 30, 2024

Last Update Submit

January 6, 2025

Conditions

Keywords

Sexual DysfunctionSexual TherapyElectromyographyPelvic Floor PhysiotherapyVaginismus

Outcome Measures

Primary Outcomes (1)

  • Surface Electromyography (sEMG)

    A 2-channel Neurotrac MyoPlus 4 Pro (Verity Medical, UK) surface electromyography (sEMG) device with testing and biofeedback features was used to measure the activity of the pelvic floor muscles, adductor and muscles

    0-6 weeks

Secondary Outcomes (3)

  • Female Sexual Function Index (FSFI)

    0-6 weeks

  • The Vaginal Penetration Cognition Questionnare (VPCQ)

    0-6 weeks

  • "Does sexual intercourse occur?"

    0-6 weeks

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants in the intervention group received pelvic floor physiotherapy combined with sexual therapy twice a week for 6 weeks.

Behavioral: sexual therapyBehavioral: Pelvic floor physiotherapy combined with sexual therapy

Control Group

EXPERIMENTAL

Participants in the control group received sexual therapy twice a week for 6 weeks.

Behavioral: sexual therapy

Interventions

sexual therapyBEHAVIORAL

In sexual therapy sessions, sexual education, cognitive restructuring, body awareness exercises, systematic desensitization, relaxation training, individual and partner home exercise training and dilator treatment were applied with the supervision of a physiotherapist. All techniques and stages were not applied in the same session and were used with a certain progression

Control GroupIntervention Group

Pelvic floor physiotherapy combined with sexual therapy was applied in the experimental group. Sexual therapy techniques were added appropriately before, during and after the pelvic floor physiotherapy session. In the pelvic floor physiotherapy sessions, pelvic floor muscle training, biofeedback, electrotherapy, manual therapy applications, breathing exercises, stretching and relaxation exercises were applied with the physiotherapist. Pelvic floor physiotherapy techniques and stages were applied in the same session and followed a certain progression.

Intervention Group

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with vaginismus,
  • Being between the ages of 20-45,
  • Having an active sexual partner in the last 6 months,
  • Not being in the accompanying physiotherapy or psychotherapy process.

You may not qualify if:

  • Diagnosed with or treated for vulvodynia and/or vulvar vestibulitis,
  • Having a pacemaker,
  • Not being able to give personal consent,
  • Having a physical problem that would prevent treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, 34810, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motor ActivitySexual Dysfunction, PhysiologicalVaginismus

Condition Hierarchy (Ancestors)

BehaviorGenital DiseasesUrogenital DiseasesVaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • Gülay Aras Bayram, PhD

    Medipol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 30, 2024

First Posted

January 7, 2025

Study Start

January 15, 2024

Primary Completion

July 31, 2024

Study Completion

August 2, 2024

Last Updated

January 8, 2025

Record last verified: 2025-01

Locations